Prolonged Effect of Inhaled Salmeterol against Exercise-Induced Bronchospasm
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Physical exercise is a common trigger for bronchial asthma. We evaluated the preventive effect on exercise-induced bronchospasm (EIB) of a single 42 micrograms dose of salmeterol, a uniquely long-acting inhaled bronchodilator, and compared salmeterol with 180 micrograms albuterol in two independent, randomized, double-blind, placebo-controlled studies involving 161 subjects. Three exercise challenges were conducted over 12 h, and bronchoconstriction following the serial challenges was assessed as change in FEV1 compared with predose values. The mean maximal percentage decrease in FEV1 after the three exercise challenges was 5% at 0.5 h, 8% at 5.5 h, and 13% at 11.5 h postdose in the salmeterol group compared with 7, 25, and 27%, respectively, in the albuterol group and 27, 27, and 26%, respectively, in the placebo group (p < 0.001, overall treatment difference). Albuterol provided complete protection against EIB (defined as < 10% decrease in FEV1 compared with predose values) only after the first exercise challenge, but salmeterol continued to provide complete protection in the majority of subjects after each exercise challenge: 80% (44 of 55) at 0.5 h, 70% (37 of 53) at 5.5 h, and 55% (29 of 53) at 11.5 h. Electrocardiographic monitoring revealed no clinically significant changes in any treatment group 15 and 30 min following each exercise challenge. In summary, these data demonstrate that salmeterol is effective against EIB and that a single 42 micrograms dose can prevent EIB for up to 12 h.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Resistance exercise is essential for preventing and treating chronic conditions such as osteoporosis in COPD or rheumatic diseases, and where catabolic drugs are often used, complicating the anorexia, cachexia and inflammation of the diseases themselves, protein supplementation may be needed as well [592,593].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [593]
Citations
Cites
Castle, W., Fuller, R., Hall, J., & Palmer, J. (1993) · BMJ · doi:10.1136/bmj.306.6884.1034 · Cited by 483
A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma
Pearlman, D. S., Chervinsky, P., LaForce, C., Seltzer, J. M., Southern, D. L., Kemp, J. P., Dockhorn, R. J., Grossman, J., Liddle, R. F., Yancey, S. W., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272004 · Cited by 362
Self-citationAnderson, S. D., Silverman, M., König, P., & Godfrey, S. (1975) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(75)90053-4 · Cited by 277
A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group
Britton, M., Earnshaw, J., & Palmer, J. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05091062 · Cited by 181
Duration of Protection by Inhaled Salmeterol in Exercise-induced Asthma
Anderson, S. D., Rodwell, L. T., du Toit, J., & Young, I. H. (1991) · CHEST Journal · doi:10.1378/chest.100.5.1254 · Cited by 120
Issues in exercise-induced asthma
Anderson, S. D. (1985) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(85)90745-6 · Cited by 106
Jack, D. B. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05571.x · Cited by 96
Henriksen, J. M., Agertoft, L., & Pedersen, S. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90302-i · Cited by 82
Kemp, J., Cw, B., & Cocchetto, D. M. (1993) · PubMed · Cited by 50
Self-citationOral and Inhaled Salbutamol in the Prevention of Exercise-Induced Bronchospasm
Francis, P. W., Krastins, I. R., & Levison, H. (1980) · PEDIATRICS · doi:10.1542/peds.66.1.103 · Cited by 46
Cited by
National Asthma Education and Prevention Program
VanGraafeiland, B. (2002) · The Nurse Practitioner · doi:10.1097/00006205-200206001-00003 · Cited by 1,091
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.
Boulet, L. P., Becker, A. B., Bérubé, D., Beveridge, R., & Ernst, P. (1999) · Europe PMC (PubMed Central) · Cited by 536
(1997) · European Respiratory Journal · doi:10.1183/09031936.97.10112662 · Cited by 345
“To maximize the likelihood of a positive response, bronchodilator agents, sodium cromoglycate and nedocromil sodium should be withheld prior to exercise for a period commensurate with their duration of action [112, 113].”
BackgroundIzquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
Nelson, H. S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330807 · Cited by 247
Metadata
- Authors
- Kemp, J. P., Dockhorn, R. J., Busse, W. W., Bleecker, E. R., & Van As, A.
- Affiliations
- Allergy and Asthma Medical Group and Research Center (US)
- Allergy and Asthma Medical Group and Research Center, San Diego, California 92123
- Venue
- American journal of respiratory and critical care medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-12-01
- Volume
- 150
- Issue
- 6
- Pages
- 1612-1615
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2078534806
- Cited by
- 85
- References
- 13
- Citations by year
- 2024: 1 · 2019: 1 · 2018: 2 · 2016: 2 · 2014: 1 · 2013: 1
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Keywords
- salmeterol, exercise-induced bronchoconstriction, asthma, salbutamol, inhaled bronchodilators, long-acting beta2-agonists, bronchoconstriction, exercise challenge, FEV1, single-dose prophylaxis
- MeSH terms
- Salmeterol Xinafoate, Administration, Inhalation, Adrenergic beta-Agonists, Adult, Albuterol, Analysis of Variance, Asthma, Exercise-Induced, Bronchodilator Agents, Double-Blind Method, Female, Forced Expiratory Volume, Humans, Male, Time Factors, Bronchoconstriction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prolonged Effect of Inhaled Salmeterol against Exercise-Induced Bronchospasm. https://app.cochat.ai/papers/10.1164/ajrccm.150.6.7952623
- The paper
- Kemp, J. P., Dockhorn, R. J., Busse, W. W., Bleecker, E. R., & Van As, A. (1994). Prolonged Effect of Inhaled Salmeterol against Exercise-Induced Bronchospasm. American journal of respiratory and critical care medicine. https://doi.org/10.1164/ajrccm.150.6.7952623
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.